A highly efficient electroporation method for the transfection of endothelial cells

Angiogenesis

Volumn 7, Issue 3, 2004, Pages 235-241

  Hernández, Jose Luis ^a   Coll, Toni ^a   Ciudad, Carlos J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Angiogenesis; Cell adhesion; Cell migration; Electroporation; Endothelial cells; Transfection; Tube like formation

Indexed keywords

ANGIOGENESIS; ARTICLE; CAPILLARY; CELL ADHESION; CELL COUNT; CELL MEMBRANE POTENTIAL; CELL MIGRATION; CONTROLLED STUDY; ELECTRIC CAPACITANCE; ELECTROPORATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UMBILICAL VEIN;

BIOLOGICAL ASSAY; ELECTROPORATION; ENDOTHELIUM, VASCULAR; GENETIC VECTORS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUSCLE PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; TRANSFECTION;

EID: 12444253003     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10456-004-4180-8     Document Type: Article

References (28)

1. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992; 3: 65-71.
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
3. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 407, 249-57.
4. Kumar CC. Integrin alpha v beta 3 as a therapeutic target for blocking tumor-induced angiogenesis. Curr Drug Targets 4: 123-31.
5. Ades EW, Candal FJ, Swerlick RA et al. HMEC-1: Establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992; 99: 683-90.
6. Fontijn R, Hop C, Brinkman HJ et al. Maintenance of vascular endothelial cell-specific properties after immortalization with an amphotrophic replication-deficient retrovirus containing human papilloma virus 16 E6/E7 DNA. Exp Cell Res 1995; 216: 199-207.
7. Sipehia R, Martucci G. High-efficiency transformation of human endothelial cells by Apo E-mediated transfection with plasmid DNA. Biochem Biophys Res Commun 1995; 214: 206-211.
8. Tanner FC, Carr DP, Nabel GJ, Nabel EG. Transfection of human endothelial cells. Cardiovasc Res 1997; 35: 522-8.
9. Teifel M, Heine LT, Milbredt S, Friedl P. Optimization of transfection of human endothelial cells. Endothelium 1997; 5: 21-35.
10. Nathwani AC, Gale KM, Pemberton KD et al. Efficient gene transfer into human umbilical vein endothelial cells allows functional analysis of the human tissue factor gene promoter. Br J Haematol 1994; 88: 122-8.
11. Kotnis RA, Thompson MM, Eady SL et al. Optimisation of gene transfer into vascular endothelial cells using electroporation. Eur J Vasc Endovasc Surg 1995; 9: 71-9.
12. Ear T, Giguere P, Fleury A et al. High efficiency transient transfection of genes in human umbilical vein endothelial cells by electroporation. J Immunol Meth 2001; 257: 41-9.
13. Merrick AF, Shewring LD, Sawyer GJ et al. Comparison of adenovirus gene transfer to vascular endothelial cells in cell culture, organ culture, and in vivo. Transplantation 1996; 62: 1085-9.
14. Wrighton CJ, Hofer-Warbinek R, Moll T et al. Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B J Exp Med 1996; 183: 1013-22.
15. Maxwell IH, Kaletta C, Naujoks K, Maxwell F. Targeting diphtheria toxin A-chain transcription to activated endothelial cells using an E-selectin promoter. Angiogenesis 2003; 6: 31-8.
16. Keely PJ, Westwick JK, Whitehead IP et al. Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature 1997; 390: 632-6.
17. Marshall JF, Rutherford DC, McCartney AC et al. Alpha v beta 1 is a receptor for vitronectin and fibrinogen, and acts with alpha 5 beta 1 to mediate spreading on fibronectin. J Cell Sci 1995; 108 (Pt 3): 1227-38.
18. Ishida T, Kundu, RK, Yang E et al. Targeted disruption of endothelial cell-selective adhesion molecule inhibits angiogenic processes in vitro and in vivo. J Biol Chem 2003; 278: 34598-604.
19. Genesca L, Aubareda A, Fuentes JJ et al. Phosphorylation of calcipressin 1 increases its ability to inhibit calcineurin and decreases calcipressin half-life. Biochem J 2003; 374: 567-75.
20. Tei K, Kawakami-Kimura N, Taguchi O et al. Roles of cell adhesion molecules in tumor angiogenesis induced by cotransplantation of cancer and endothelial cells to nude rats. Cancer Res 2002; 62: 6289-96.
21. Soeda S, Shibata Y, Shimeno H. Inhibitory effect of oversulfated fucoidan on tube formation by human vascular endothelial cells. Biol Pharm Bull 1997; 20: 1131-5.
22. Kurzen H, Schmitt S, Naher H, Mohler T. Inhibition of angiogenesis by non-toxic doses of temozolomide. Anticancer Drugs 2003; 14: 515-22.
23. Ivanov D, Philippova M, Tkachuk V et al. Cell adhesion molecule T-cadherin regulates vascular cell adhesion, phenotype and motility. Exp Cell Res 2004; 293: 207-18.
24. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-64.
25. Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med 1971; 285: 1182-6.
26. Naik MU, Vuppalanchi D, Naik UP. Essential role of junctional adhesion molecule-1 in basic fibroblast growth factor-induced endothelial cell migration. Arterioscler Thromb Vasc Biol 2003; 23: 2165-71.
27. Rozic JG, Chakraborty C, Lala PK. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis. Int J Cancer 2001 93: 497-506.
28. Lang Z, Guerrera M, Li R, Ladisch S. Ganglioside GD1a enhances VEGF-induced endothelial cell proliferation and migration. Biochem Biophys Res Commun 2001; 282: 1031-7.